Apexigen Inc
Change company Symbol lookup
Select an option...
APGN Apexigen Inc
CO Global Cord Blood Corp
AHT-G Ashford Hospitality Trust Inc
LUVU Luvu Brands Inc
MYD BlackRock MuniYield
NMG Nouveau Monde Graphite Inc
VLYPO Valley National Bancorp
PEPL PepperLime Health Acquisition Corp
GAINN Gladstone Investment Corp
SUPN Supernus Pharmaceuticals Inc
Go

Company profile

Apexigen, Inc., formerly Brookline Capital Acquisition Corp., is a clinical-stage biopharmaceutical company. The Company is focused on developing antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. It has a diversified pipeline of wholly owned and partnered assets leveraging its APXiMAB antibody discovery platform. The Company’s pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in Phase II clinical development, and also includes several preclinical stage immuno-oncology programs. The Company’s lead asset, sotigalimab, is a CD40 agonist with epitope specificity and Fc receptor engagement for optimal therapeutic effect. Its sotigalimab is used for the treatment of Melanoma (post PD-1), Esophageal/GEJ, Sarcoma, Rectal and Ovarian cancers. Its pipeline also includes APX601 and APX801. It has out-licensed five programs for the development of product candidates that were discovered using the APXiMAB platform.

Closing Price
$2.70
Day's Change
0.05 (1.89%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.81
Day's Low
2.38
Volume
(Light)
Volume:
109,653

10-day average volume:
251,576
109,653
  • Prev Close
    2.65
  • Today's Open
    2.57
  • Day's Range
    2.38-2.81
  • Avg Vol (10-day)
    251.6K
  • Last (time)
    4:00p ET 09/30/22
  • Last (size)
    93
  • 52-Wk Range
    2.38 - 31.35
    LowHigh
  • (08/01/22 - 09/30/22)
    13.45%
  • 118.8%
  • Market Cap
    57.9M
  • Shares Outstanding
    21.4M
  • -0.58
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 27.36
  • (% of float 09/15/22)
    0.20

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.